We are live on ! Find out more
IMMP

Immutep

4 hedge funds and large institutions have $67K invested in Immutep in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

33% less funds holding

Funds holding: 64 (-2)

46% less capital invested

Capital invested by funds: $125K → $67K (-$58K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WPC
1
Waters Parkerson & Co
Louisiana
$38K
VWM
2
Valley Wealth Managers
New Jersey
$19K
UBS Group
3
UBS Group
Switzerland
$10K +$1.09K +596 +12%
SM
4
Sabby Management
Florida
-$34K -21,500 Closed
Ameriprise
5
Ameriprise
Minnesota
-$31K -20,000 Closed
Morgan Stanley
6
Morgan Stanley
New York
-$5K -3,000 Closed
BFC
7
Bedel Financial Consulting
Indiana
+$71 +39 New

IMMP Hedge Fund Activity: Q1 2018 in Review

4 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q1 2018, worth a combined $67K — down 46% from $125K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of IMMP and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $1.09K. The largest seller was Sabby Management, exiting entirely with an estimated $34K sold.

  • 4 institutional investors held Immutep (IMMP) as of Q1 2018, down from 6 in Q4 2017.
  • Funds reported $67K of Immutep stock for Q1 2018, down 46% quarter-over-quarter.
  • 1 fund opened new Immutep positions in Q1 2018 and 3 closed out, a net change of -2 holders.
  • The largest Immutep buyer in Q1 2018 was UBS Group, an estimated $1.09K added.
  • The largest Immutep seller in Q1 2018 was Sabby Management, an estimated $34K sold.

Based on aggregated 13F filings for Q1 2018.